Inventor
CHANG HEE PARK
Inventor
KR
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds10%
PatentTitleYear
12,344,618Heterotricyclic derivative compound and use of same202511,649,246Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof202311,254,676Pyrazole derivative compound and use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to HANMI PHARM IND CO LTD (2)· patent assignee history
2022–2025Based in KR· patent location history
2025Patents assigned to HANMI PHARMACEUTICAL CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HANMI PHARM IND CO LTD | 2 | 2022–2023 |
| HANMI PHARMACEUTICAL CO LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 3 | 2022–2025 |